B
Bhabani Mohanty
Researcher at Cancer Research Institute
Publications - 16
Citations - 160
Bhabani Mohanty is an academic researcher from Cancer Research Institute. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 6, co-authored 9 publications receiving 87 citations.
Papers
More filters
Journal ArticleDOI
Enhanced skin permeation of Methotrexate from penetration enhancer containing vesicles: In vitro optimization and in vivo evaluation.
Bhakti Sadarani,Anuradha Majumdar,Shalaka Paradkar,Anupam Mathur,Satbir S. Sachdev,Bhabani Mohanty,Pradip Chaudhari +6 more
TL;DR: The optimized MTX nanogel formulation displayed skin biocompatibility, sustained systemic delivery, safety as well as therapeutic efficacy, for low dose Methotrexate therapy.
Journal ArticleDOI
ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer
Prajish Iyer,Shailesh V. Shrikhande,Malika Ranjan,Asim Joshi,Nilesh Gardi,Ratnam Prasad,Bhasker Dharavath,Rahul Thorat,Sameer Salunkhe,Bikram Sahoo,Pratik Chandrani,Hitesh Kore,Bhabani Mohanty,Vikram Chaudhari,Anuradha Choughule,Dhananjay Kawle,Pradip Chaudhari,Arvind Ingle,Shripad Banavali,Poonam Gera,Mukta Ramadwar,Kumar Prabhash,Savio George Barreto,Shilpee Dutt,Amit Dutt +24 more
TL;DR: Overall, besides implicating ERBB2 as an important therapeutic target under neo‐adjuvant or adjuvant settings, this work presents the first evidence that the presence of KRAS mutations may preclude gallbladder cancer patients to respond to anti‐ EGFR treatment, similar to a clinical algorithm commonly practiced to opt for anti‐EGFR treatment in colorectal cancer.
Journal ArticleDOI
Accentuated osseointegration in osteogenic nanofibrous coated titanium implants
Siddhartha Das,Kanchan P. Dholam,Sandeep V Gurav,Kiran Bendale,Arvind Ingle,Bhabani Mohanty,Pradip Chaudhari,Jayesh R. Bellare +7 more
TL;DR: The findings of the present study confirm that osteogenic nanofibrous coating significantly increases the magnitude of osteogenesis in the peri-implant zone and favours the dynamics of osseointegration.
Journal ArticleDOI
Oral administration of 3,3'-diselenodipropionic acid prevents thoracic radiation induced pneumonitis in mice by suppressing NF-kB/IL-17/G-CSF/neutrophil axis.
K.A. Gandhi,Jayant Sastri Goda,V.V. Gandhi,A. Sadanpurwala,V.K. Jain,Kusum Joshi,S. Epari,Swapnil Rane,Bhabani Mohanty,Pradip Chaudhari,S. Kembhavi,Amit Kunwar,Amit Kunwar,Vikram Gota,K.I. Priyadarsini,K.I. Priyadarsini +15 more
TL;DR: DSePA offers protection to normal lung against RP without affecting radiation sensitivity of tumors, and has the potential to be developed as an oral agent for preventing RP.